An X chromosome gene appears to drive inflammation in the brain, and may explain why women are more likely to develop MS, per ...

An MS relapse and the end of a relationship leave columnist Ahna Crum feeling unsafe and unsure about the world around her.

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

Trageting abnormal brain cells linked to chronic inflammation may be key to treating people with progressive forms of MS, a ...

Jana Hlavacova, a Czech government employee who lives with MS, is helping shape policies in healthcare and the design of ...

Tr1X has won an FDA green light for a clinical trial testing TRX319, a cell therapy designed to restore immune balance, for ...

Jill Blackburn, a pediatric MS mom, founded the Pediatric Multiple Sclerosis Alliance to help other families of kids with the ...

EG110A received FDA fast track designation to treat neurogenic detrusor overactivity, a bladder issue common in MS.

Researchers have identified two experimental medications that may be able to promote myelin repair in people with MS, a study ...

Compassion means listening to your body without guilt and sometimes avoiding just "pushing through," writes columnist.

Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...

The Valhalla Foundation awarded Octave Bioscience funding to further develop a biomarker blood test for assessing disease ...